Whats new

Whats new.

goetzpartners securities - Targeting first-line head and neck with Merck & Co

March 16th 2021

This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clients.

Go back